Bsenexus Terminal Open Filings terminal →
Conference call BSE: 500660

GlaxoSmithKline Pharmaceuticals Ltd

GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

As per attachment